Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate for Central Serous Chorioretinopathy
NCT01633983Phase 2Unknown
- Start
- Aug 2012
- Primary completion
- Jul 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate in Central Serous Chorioretinopathy (CSCR). Status: unknown.
02
Drugs
methotrexate
03
Conditions
Central Serous Chorioretinopathy (CSCR)
Beyond the preview
Go deeper on NCT01633983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01633983.